Pharmaceutical industry supports trade deal

Published: 2010-12-07 06:59:00

Updated: 2010-12-07 06:59:00

Korea's pharmaceutical sector is showing positive response to the free trade agreement (FTA) signed between Korea and the U.S. over the weekend.

The pharmaceutical industry expressed support for the pact, expecting Korean drugmakers to increase their R&D investment from 7 percent to 10 percent...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK